Home/Filings/4/0001213900-23-019553
4//SEC Filing

Ofir Guy 4

Accession 0001213900-23-019553

CIK 0001415397other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 4:01 PM ET

Size

6.7 KB

Accession

0001213900-23-019553

Insider Transaction Report

Form 4
Period: 2022-07-26
Ofir Guy
DirectorPresident10% Owner
Transactions
  • Award

    Warrants to Purchase Common Stock

    2022-12-05+1,000,0001,000,000 total
    Exercise: $1.00Exp: 2025-12-31Common Stock (1,000,000 underlying)
  • Award

    Common Stock

    2022-07-26+1,000,0001,266,455 total
Footnotes (1)
  • [F1]The warrants are exercisable immediately.

Documents

1 file

Issuer

Raphael Pharmaceutical Inc.

CIK 0001415397

Entity typeother

Related Parties

1
  • filerCIK 0001424145

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 4:01 PM ET
Size
6.7 KB